Management of Influenza A After the 48-Hour Window

Antiviral Therapy Decision

The American College of Physicians recommends that oseltamivir should not be given to otherwise healthy outpatients presenting more than 48 hours after symptom onset, as no data support symptomatic benefit when treatment is initiated after one week in previously healthy, non-hospitalized patients 1
Oseltamivir should be given if the patient has any high-risk features, such as age less than 2 years or greater than or equal to 65 years, pregnancy or postpartum, immunocompromised status, chronic cardiac, pulmonary, renal, hepatic, neurologic, or metabolic disease, severe or progressive illness requiring hospitalization, or evidence of complications, as mortality benefit persists when initiated up to 96 hours after symptom onset in high-risk patients 1, 2, 3

The American Academy of Family Physicians recommends acetaminophen as first-line antipyretic/analgesic for fever and body aches, and ibuprofen as an alternative, with the goal of alleviating distressing symptoms, not solely reducing temperature 3
The Centers for Disease Control and Prevention suggest additional supportive measures, including adequate hydration, rest, avoiding smoking, and using short-term topical decongestants, throat lozenges, or saline nose drops as needed 2, 3

The Infectious Diseases Society of America recommends instructing the patient to return immediately if they develop shortness of breath, painful or difficult breathing, bloody sputum, drowsiness, disorientation, or confusion, or if they experience fever persisting more than 4-5 days without improvement or initial improvement followed by recurrence of high fever 2, 3

The American College of Chest Physicians recommends not empirically adding antibiotics unless there is evidence of bacterial superinfection, and using antibiotics covering S. pneumoniae, S. aureus, and H. influenzae if bacterial superinfection is suspected 1, 4
The Society for Healthcare Epidemiology of America suggests indications to add antibiotics, including new consolidation on chest imaging, purulent sputum production, clinical deterioration despite supportive care, and elevated inflammatory markers suggesting bacterial infection 1, 3

The World Health Organization recommends not reflexively prescribing antibiotics for viral influenza symptoms alone, as this contributes to antibiotic resistance, and not withholding oseltamivir in high-risk patients based solely on timing, as mortality benefit persists even when started 48-96 hours after symptom onset 1, 2
The American Academy of Pediatrics recommends not using aspirin in children less than 16 years due to Reye's syndrome risk 3

The Centers for Disease Control and Prevention recommend advising the patient on transmission prevention, including hand hygiene, respiratory etiquette, and considering post-exposure prophylaxis with oseltamivir 75 mg once daily for 10 days for high-risk household contacts 1, 2, 3